International Recommendations

VTE Treatment

The table below provides a brief summary of the ACCP 2008 International Recommendations for the treatment of VTE.  If you would like to view complete recommendations, please visit http://www.chestjournal.org

ACCP 2008
Treatment of Superficial Vein Thrombosis

Prophylactic or Intermediate dose of LMWH (2B) or intermediate dose of UFH (2B) for at least 4 weeks.
Alternative: 5 days of LMWH/Low-dose UFH + VKA for 4 weeks
Initial Treatment of DVT lower limb or PE Therapeutic dose of LMWH, UFH, Fondaparinux: 1A;
for at least 5 days : 1C
Patients with DVT or PE & cancer
  • LMWH for the first 3 to 6 months: 1A
  • Subsequently LMWH or VKA: 1C
Treatment of Upper Extremity DVT Therapeutic dose of LMWH, UFH, Fondaparinux: 1C
(then VKA)

For diagnosis and management of acute pulmonary embolism (PE), please read the ESC 2008 Guidelines

Please Log in
Free registration to access disease diagnosis, patient management, physician tools.

Only registered users have access to this content.

Already Registered?

Email    Password   

Not a member?

Don't worry, registration is quick and FREE! We welcome all Healthcare professionals, doctors, nurses and medical students. 

Register today to have full access to a wealth of drug data, educational and evidence based interactive guides across all major theraputic areas, disease management, and clinical tools.

As a practicing Healthcare professional, you can also opt-in to join our market research panel – www.epgsurvey.com – and get paid for sharing your expert clinical opinions!

REGISTER today it only takes a minute! and it's FREE

If you are not a healthcare professional please visit our patient site.

Having problems?

Use our forgotten password facility or email us at: contact@epgonline.org

Exit Log in